Skip to content

Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition

Research output: Contribution to journalReview article

Standard

Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II : Neurochemistry, neurophysiology and neurocognition. / Bandelow, Borwin; Baldwin, David; Abelli, Marianna; Bolea-Alamanac, Blanca; Bourin, Michel; Chamberlain, Samuel R; Cinosi, Eduardo; Davies, Simon; Domschke, Katharina; Fineberg, Naomi; Grünblatt, Edna; Jarema, Marek; Kim, Yong-Ku; Maron, Eduard; Masdrakis, Vasileios; Mikova, Olya; Nutt, David; Pallanti, Stefano; Pini, Stefano; Ströhle, Andreas; Thibaut, Florence; Vaghi, Matilde M; Won, Eunsoo; Wedekind, Dirk; Wichniak, Adam; Woolley, Jade; Zwanzger, Peter; Riederer, Peter.

In: World Journal of Biological Psychiatry, Vol. 18, No. 3, 04.2017, p. 162-214.

Research output: Contribution to journalReview article

Harvard

Bandelow, B, Baldwin, D, Abelli, M, Bolea-Alamanac, B, Bourin, M, Chamberlain, SR, Cinosi, E, Davies, S, Domschke, K, Fineberg, N, Grünblatt, E, Jarema, M, Kim, Y-K, Maron, E, Masdrakis, V, Mikova, O, Nutt, D, Pallanti, S, Pini, S, Ströhle, A, Thibaut, F, Vaghi, MM, Won, E, Wedekind, D, Wichniak, A, Woolley, J, Zwanzger, P & Riederer, P 2017, 'Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition', World Journal of Biological Psychiatry, vol. 18, no. 3, pp. 162-214. https://doi.org/10.1080/15622975.2016.1190867

APA

Bandelow, B., Baldwin, D., Abelli, M., Bolea-Alamanac, B., Bourin, M., Chamberlain, S. R., ... Riederer, P. (2017). Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition. World Journal of Biological Psychiatry, 18(3), 162-214. https://doi.org/10.1080/15622975.2016.1190867

Vancouver

Bandelow B, Baldwin D, Abelli M, Bolea-Alamanac B, Bourin M, Chamberlain SR et al. Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition. World Journal of Biological Psychiatry. 2017 Apr;18(3):162-214. https://doi.org/10.1080/15622975.2016.1190867

Author

Bandelow, Borwin ; Baldwin, David ; Abelli, Marianna ; Bolea-Alamanac, Blanca ; Bourin, Michel ; Chamberlain, Samuel R ; Cinosi, Eduardo ; Davies, Simon ; Domschke, Katharina ; Fineberg, Naomi ; Grünblatt, Edna ; Jarema, Marek ; Kim, Yong-Ku ; Maron, Eduard ; Masdrakis, Vasileios ; Mikova, Olya ; Nutt, David ; Pallanti, Stefano ; Pini, Stefano ; Ströhle, Andreas ; Thibaut, Florence ; Vaghi, Matilde M ; Won, Eunsoo ; Wedekind, Dirk ; Wichniak, Adam ; Woolley, Jade ; Zwanzger, Peter ; Riederer, Peter. / Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II : Neurochemistry, neurophysiology and neurocognition. In: World Journal of Biological Psychiatry. 2017 ; Vol. 18, No. 3. pp. 162-214.

Bibtex

@article{644cd24b1c4945c8aa7c86f7376981e9,
title = "Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition",
abstract = "OBJECTIVE: Biomarkers are defined as anatomical, biochemical or physiological traits that are specific to certain disorders or syndromes. The objective of this paper is to summarise the current knowledge of biomarkers for anxiety disorders, obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD).METHODS: Findings in biomarker research were reviewed by a task force of international experts in the field, consisting of members of the World Federation of Societies for Biological Psychiatry Task Force on Biological Markers and of the European College of Neuropsychopharmacology Anxiety Disorders Research Network.RESULTS: The present article (Part II) summarises findings on potential biomarkers in neurochemistry (neurotransmitters such as serotonin, norepinephrine, dopamine or GABA, neuropeptides such as cholecystokinin, neurokinins, atrial natriuretic peptide, or oxytocin, the HPA axis, neurotrophic factors such as NGF and BDNF, immunology and CO2 hypersensitivity), neurophysiology (EEG, heart rate variability) and neurocognition. The accompanying paper (Part I) focuses on neuroimaging and genetics.CONCLUSIONS: Although at present, none of the putative biomarkers is sufficient and specific as a diagnostic tool, an abundance of high quality research has accumulated that should improve our understanding of the neurobiological causes of anxiety disorders, OCD and PTSD.",
keywords = "Advisory Committees, Anxiety Disorders, Biological Psychiatry, Biomarkers, Consensus, Humans, Obsessive-Compulsive Disorder, Randomized Controlled Trials as Topic, Societies, Medical, Stress Disorders, Post-Traumatic, Journal Article, Review",
author = "Borwin Bandelow and David Baldwin and Marianna Abelli and Blanca Bolea-Alamanac and Michel Bourin and Chamberlain, {Samuel R} and Eduardo Cinosi and Simon Davies and Katharina Domschke and Naomi Fineberg and Edna Gr{\"u}nblatt and Marek Jarema and Yong-Ku Kim and Eduard Maron and Vasileios Masdrakis and Olya Mikova and David Nutt and Stefano Pallanti and Stefano Pini and Andreas Str{\"o}hle and Florence Thibaut and Vaghi, {Matilde M} and Eunsoo Won and Dirk Wedekind and Adam Wichniak and Jade Woolley and Peter Zwanzger and Peter Riederer",
year = "2017",
month = "4",
doi = "10.1080/15622975.2016.1190867",
language = "English",
volume = "18",
pages = "162--214",
journal = "World Journal of Biological Psychiatry",
issn = "1562-2975",
publisher = "Informa Healthcare",
number = "3",

}

RIS - suitable for import to EndNote

TY - JOUR

T1 - Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II

T2 - Neurochemistry, neurophysiology and neurocognition

AU - Bandelow, Borwin

AU - Baldwin, David

AU - Abelli, Marianna

AU - Bolea-Alamanac, Blanca

AU - Bourin, Michel

AU - Chamberlain, Samuel R

AU - Cinosi, Eduardo

AU - Davies, Simon

AU - Domschke, Katharina

AU - Fineberg, Naomi

AU - Grünblatt, Edna

AU - Jarema, Marek

AU - Kim, Yong-Ku

AU - Maron, Eduard

AU - Masdrakis, Vasileios

AU - Mikova, Olya

AU - Nutt, David

AU - Pallanti, Stefano

AU - Pini, Stefano

AU - Ströhle, Andreas

AU - Thibaut, Florence

AU - Vaghi, Matilde M

AU - Won, Eunsoo

AU - Wedekind, Dirk

AU - Wichniak, Adam

AU - Woolley, Jade

AU - Zwanzger, Peter

AU - Riederer, Peter

PY - 2017/4

Y1 - 2017/4

N2 - OBJECTIVE: Biomarkers are defined as anatomical, biochemical or physiological traits that are specific to certain disorders or syndromes. The objective of this paper is to summarise the current knowledge of biomarkers for anxiety disorders, obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD).METHODS: Findings in biomarker research were reviewed by a task force of international experts in the field, consisting of members of the World Federation of Societies for Biological Psychiatry Task Force on Biological Markers and of the European College of Neuropsychopharmacology Anxiety Disorders Research Network.RESULTS: The present article (Part II) summarises findings on potential biomarkers in neurochemistry (neurotransmitters such as serotonin, norepinephrine, dopamine or GABA, neuropeptides such as cholecystokinin, neurokinins, atrial natriuretic peptide, or oxytocin, the HPA axis, neurotrophic factors such as NGF and BDNF, immunology and CO2 hypersensitivity), neurophysiology (EEG, heart rate variability) and neurocognition. The accompanying paper (Part I) focuses on neuroimaging and genetics.CONCLUSIONS: Although at present, none of the putative biomarkers is sufficient and specific as a diagnostic tool, an abundance of high quality research has accumulated that should improve our understanding of the neurobiological causes of anxiety disorders, OCD and PTSD.

AB - OBJECTIVE: Biomarkers are defined as anatomical, biochemical or physiological traits that are specific to certain disorders or syndromes. The objective of this paper is to summarise the current knowledge of biomarkers for anxiety disorders, obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD).METHODS: Findings in biomarker research were reviewed by a task force of international experts in the field, consisting of members of the World Federation of Societies for Biological Psychiatry Task Force on Biological Markers and of the European College of Neuropsychopharmacology Anxiety Disorders Research Network.RESULTS: The present article (Part II) summarises findings on potential biomarkers in neurochemistry (neurotransmitters such as serotonin, norepinephrine, dopamine or GABA, neuropeptides such as cholecystokinin, neurokinins, atrial natriuretic peptide, or oxytocin, the HPA axis, neurotrophic factors such as NGF and BDNF, immunology and CO2 hypersensitivity), neurophysiology (EEG, heart rate variability) and neurocognition. The accompanying paper (Part I) focuses on neuroimaging and genetics.CONCLUSIONS: Although at present, none of the putative biomarkers is sufficient and specific as a diagnostic tool, an abundance of high quality research has accumulated that should improve our understanding of the neurobiological causes of anxiety disorders, OCD and PTSD.

KW - Advisory Committees

KW - Anxiety Disorders

KW - Biological Psychiatry

KW - Biomarkers

KW - Consensus

KW - Humans

KW - Obsessive-Compulsive Disorder

KW - Randomized Controlled Trials as Topic

KW - Societies, Medical

KW - Stress Disorders, Post-Traumatic

KW - Journal Article

KW - Review

U2 - 10.1080/15622975.2016.1190867

DO - 10.1080/15622975.2016.1190867

M3 - Review article

C2 - 27419272

VL - 18

SP - 162

EP - 214

JO - World Journal of Biological Psychiatry

JF - World Journal of Biological Psychiatry

SN - 1562-2975

IS - 3

ER -